Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02197273 · ClinicalTrials.gov registry record · NA

Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)

A NA study, sponsored by OhioHealth.

Completed
Registry status
NA
Development phase
211
Enrollment target

NCT02197273: Completed NA study, sponsored by OhioHealth.

NCT02197273 is a NA study that has completed, run by OhioHealth. The registered enrollment target is 211 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02197273, a NA study, has completed, sponsored by OhioHealth.

COMPLETED
Registry status
NA
Development phase
211 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total joint arthroplasty, as compared to standard of care analgesia.

Interventions

  • DRUG Liposomal bupivacaine
  • DRUG Standard of care analgesia

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 2014-07
Est. Completion 2015-10
Phase NA
OhioHealth

20 total trials

What the finished NCT02197273 record still lists

NCT02197273 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Liposomal bupivacaine is the first listed.

NCT02197273 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02197273 about?

NCT02197273 is a clinical study titled "Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)". The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total joint arthroplasty, as compared to standard of care analgesia.

What is the current status of trial NCT02197273?

This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2014-07. Estimated completion is 2015-10.

What interventions are being tested in trial NCT02197273?

The interventions under investigation include: Liposomal bupivacaine (DRUG), Standard of care analgesia (DRUG).

Who is sponsoring clinical trial NCT02197273?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02197273's enrollment target sits among peer trials

211 490th of 2000 higher than 1,511 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06698796 · 211 participants · Phase 3

    A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02197273, the US trial registry maintained by the National Library of Medicine. NCT02197273 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.